Everolimus (Afinator) is approved to treat:

• Breast cancer. Everolimus is used in combination with exemestane in post menopausal women with advanced hormone receptor positive (HR+) breast cancer that is also HER2 negative   (HER2-) and has not gotten better with other chemotherapy.
• Pancreatic cancer. It is used in adults with progressive neuroendocrine tumorsthat cannot be removed by surgery, are locally advanced, or have metastasized(spread to other parts of the body).
• Renal cell carcinoma (a type of kidney cancer) that is advanced, in adults who have not gotten better with other chemotherapy.
• Subependymal giant cell astrocytoma in adults and children who have tuberous sclerosis and are not able to have surgery. Everolimus is available as tablets (Afinitor) or tablets for oral suspension (Afinitor Disperz). Only Afinitor Disperz is used in children.